Mice as models of human developmental disorders: Natural and artificial mutants

Current Opinion in Genetics and Development

Volumn 6, Issue 3, 1996, Pages 289-294

  Darling, Susan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BONE DISEASE; CLEFT PALATE; DEVELOPMENTAL DISORDER; EMBRYO DEVELOPMENT; GENE MUTATION; GENETIC MODEL; HEARING IMPAIRMENT; MOUSE; MOUSE MUTANT; NEURAL TUBE DEFECT; NONHUMAN; OBESITY; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALIA; MAMMALIA;

EID: 0030015289     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)80004-9     Document Type: Article

References (49)

1. Muenke M: Finding genes involved in human developmental disorders. Curr Opin Genet Dev 1995, 5:354-361.
2. Lyon MF, Rastan S, Brown SDM (Eds): In Genetic variants and strains of the laboratory mouse, edn 3. Oxford: Oxford University Press; 1996. This book, now in two volumes, provides a unique source of information on natural mouse mutants in addition to other catalogues including mouse chromosome variants, inbred and wild strains.
3. Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Connor TJ et al.: A comprehensive genetic map of the mouse genome. Nature 1996, 380:149-152.
4. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: a compendium of knockouts (part I). Curr Biol 1995, 5:625-634. See annotation [6•].
5. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: a compendium of knockouts (part II). Curr Biol 1995, 5:758-765. See annotation [6•].
6. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: a compendium of knockouts (part III). Curr Biol 1995, 5:873-881. A useful compendium of gene-targeted mutations in the mouse.
7. Steel KP, Brown SDM: Genes and deafness. Trends Genet 1994, 10:428-435. An in-depth review describing the many mouse and human deafness defects and identified deafness genes.
8. Gibson F, Walsh J, Mburu P, Varel A, Brown KA, Antonio M, Beisel KW, Steel KP, Brown SDM: A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995, 374:52-64. This paper describes the identification of the first gene known to be involved in auditory transduction by virtue of its abnormal phenotype.
9. Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD et al.: Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995, 374:60-61.
10. Avraham KB, Hasson T, Steel KP, Kingsley DM, Russell LB, Mooseker MS, Copeland NG, Jenkins NA: The mouse Snell's weltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nat Genet 1995, 11:369-375. A description both of the identification of the Myo6 gene and the phenotypic defects associated with the Snell's waltzer mutation.
11. Copp AJ, Frances AB, Estibeiro P, Shum ASW, Cockroft DL: The embryonic development of mammalian neural tube defects. Prog Neurobiol 1990, 35:363-403.
12. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR: High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995, 5:931-936. See annotation [13•].
13. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T: A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 1995, 10:175-180. Both these papers [12•, 13•] provide in-depth discussions as to how the p53 mutation might lead to failure to close the neural tube.
14. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 1991, 67:767-774.
15. Neumann PE, Frankel WN, Letts VA, Coffin JM, Copp AJ, Bernfield M: Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice. Nat Genet 1994, 6:357-362.
16. Alles A, Sulik KK: Retinoic acid-induced spina bifida: evidence for a pathogenetic mechanism. Development 1990, 108:73-81.
17. Helwig U, Imai K, Schmal W, Thomas BE, Varnum DS, Nadeau JH, Balling R: Interaction between undulated and Patch leads to an extreme form of spina bifida in double-mutant mice. Nat Genet 1995, 11:60-63. An interesting paper, describing an unexpected result and demonstrating the usefulness of the approach of inter-crossing mouse mutants.
18. Estibeiro JP, Brook FA, Copp AJ: Interaction between splotch (Sp) and curly tail (ct) mouse mutants in the embryonic development of neural tube defects. Development 1993, 119:113-121.
19. Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH: Brca-t deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996, 12:191-194.
20. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T: Transforming growth factor-β3 is required for secondary palate fusion. Nat Genet 1995, 11:409-414. This paper and [21••] show that mice lacking TGF-β3 exhibit cleft palate, demonstrating a role for this factor in palatal shelf fusion. Significantly, the cleft palate is not accompanied by craniofacial defects, emphasising that the TGF-β3-deficiency phenotype results from an intrinsic primary defect in palatal shelf fusion, rather than as a secondary consequence of craniofacial abnormalities.
21. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J: Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995, 11:415-421. Along with annotation [20••], the TGF-β3-deficient mice described in this paper also show delayed development of the lungs - a feature consistent with the expression pattern of the gene during embryogenesis.
22. Culiat CT, Stubbs LJ, Woychik RP, Russell LB, Johnson DK, Rinchik EM: Deficiency of the β3 subunit of the type A γ-aminobutyric acid receptor causes cleft palate in mice. Nat Genet 1995, 11:344-346. An interesting paper, describing an alternative approach to identifying genes involved in cleft palate. The authors elegantly test the hypothesis that deletion of Gabrb3 alone, and not another gene within the deletion interval, causes cleft palate. The cleft palate phenotype is rescued by introducing a Gabrb3 transgene into mice homozygous for the deletion.
23. Jacenko O, Olsen BR: Transgenic mouse models in studies of skeletal disorders. J Rheumatol 1995, 22(suppl 43):39-41.
24. Muenke M, Schell U: Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 1995, 11:308-313.
25. Hastbacka J, De la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, Hamilton BA, Kusumi K, Trivedi B, Weaver A, Coloma A et al.: The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994, 78:1073-1087.
26. Li D, Lacerda DA, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, AndrikopoulosK, Ramirez F et al.: A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell 1995, 80:423-430. The authors demonstrate thai collagen XI is essential for normal formation of cartilage collagen fibrils and for the cohesive properties of cartilage by identifying the molecular basis of the mouse mutant chondrodysplasia as a result of linkage analysis. Mice homozygous for the mutation show no detectable collagen XI in their cartilage as a result of a single nucleotide deletion in the coding region of the Col11a1 gene.
27. Vikkula M, Mariman ECM, Lui VCH, Zhidkova NI, Tiller GE, Goldring MB, Van Beersum SEC, De Waal Malefijt MC, Van den Hoogen FHJ, Ropers H-H et al.: Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995, 80:431-437.
28. Li S-W, Prockop DJ, Helminen H, Fassler R, Lapvetelainen T, Kiraly K, Peltarri A, Arokoski J, Lui H, Arita M, Khillan JS: Transgenic mice with targeted inactivation of the Col2a1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev 1995, 9:2821-2830.
29. Fassler R, Schnegelsberg PNJ, Dausman J, Shinya T, Muragaki Y, McCarthy MT, Olsen BR, Jaenisch R: Mice lacking α1(IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA 1994, 91:5070-5074.
30. Andrikopoulos K, Liu X, Keene DR, Jaenisch R, Ramirez F: Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 1995, 9:31-36.
31. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P: Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84:911-921. This paper and [32••] show that targeted disruption of Fgfr3 produces severe and progressive bone dysplasia with enhanced and prolonged endochondral bone growth. The authors therefore propose that Fgfr3 appears to regulate endochondral ossification by a negative mechanism to limit rather than promote growth.
32. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996, 12:390-397. See annotation [31••]. Interestingly, the Fgfr3-deficient mice described in this paper show inner ear defects in addition to the skeletal overgrowth, demonstrating essential roles for the receptor in both endochondral ossification and development of the organ of Corti.
33. Siracusa LD: The agouti gene: turned on to yellow. Trends Genet 1994, 10:423-428.
34. Bultman SJ, Michaud EJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell 1992, 71:1195-1204.
35. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. This paper describes the molecular identification of the mouse obese gene using a positional cloning strategy. The predicted amino acid sequence shows 84% identity between human and mouse and exhibits features of a secreted protein suggesting that the obese product may function as part of a signalling pathway from adipose tissue that acts to regulate body fat deposition.
36. Coleman DL: Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973, 9:294-298.
37. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:541-543. See annotation [39•].
38. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546. See annotation [39•].
39. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549. These three papers, [37•-39•], present the results of physiological experiments on lean and obese mice to determine how the leptin protein functions.
40. Lonnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1995, 1:950-953.
41. Hamilton BS, Paglia D, Kwan AYM, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995, 1:953-956.
42. Green ED, Maffei M, Braden VV, Proenca R, DeSilva U, Zhang Y, Chua SC Jr, Leibel RL, Weissenbach J, Friedman JM: The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res 5:5-12.
43. Tartaglia LA, Dembski M, Weng X, Deng NH, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J et al.: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271. The authors identify and clone a receptor for the obese gene product, leptin, by screening a cDNA expression library with a leptin - alkaline phosphatase fusion protein. They present evidence that the gene encoding the receptor maps close to a region of mouse chromosome 4 where another obesity mutation, diabetes, has previously been localised.
44. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:362-635.
45. Chen H, Chariat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE et al., Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
46. Collins FS: Positional cloning moves from the perditional to traditional. Nat Genet 1995, 9:347-350.
47. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH: Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995, 10:135-142. The first demonstration of an obesity/diabetes syndrome caused by a genetic defect in a prohormone processing pathway.
48. Noben-Trauth K, Naggert JK, North WA, Nishima PM: A candidate gene for the mouse mutation tubby. Nature 1996, 380:534-538.
49. Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC, Wu Y, Berkemeier LR, Misumi DJ, Holmgren L, Charlat O et al.: Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996, 85:281-290.